CYP2J2 and pulmonary arterial hypertension: In this study, we demonstrated that CYP2J2 overexpression and EETs could alleviate LIRI, when combined with PAH, through anti-inflammation, anti-oxidative stress and anti-apoptosis while improving PAH vascular remodeling.